Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Medullary × Radiotherapy × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 61 Glioblastoma 51 Lung Neoplasms 48 Breast Neoplasms 44 Prostatic Neoplasms 39 Head and Neck Neoplasms 38 Squamous Cell Carcinoma of Head and Neck 33 Esophageal Neoplasms 30 Brain Neoplasms 28 Lymphoma 27 Gliosarcoma 26 Rectal Neoplasms 24 Hodgkin Disease 24 Pancreatic Neoplasms 22 Adenocarcinoma Of Esophagus 22 Central Nervous System Neoplasms 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Neoplasms 20 Lymphoma, Non-Hodgkin 17 Leukemia 17 Glioma 17 Burkitt Lymphoma 16 Sarcoma 15 Lymphoma, Large B-Cell, Diffuse 15 Lymphoma, Follicular 14 Carcinoma, Squamous Cell 14 Colorectal Neoplasms 13 Astrocytoma 13 Neoplasm Metastasis 12 Lymphoma, B-Cell, Marginal Zone 12

Interventions

vandetanib 9 cabozantinib 5 selpercatinib 4 Sorafenib 3 Sunitinib 2 yeast-CEA vaccine 1 tanespimycin 1 rovalpituzumab tesirine 1 pralsetinib 1 pembrolizumab 1 pazopanib 1 lenvatinib 1 Vorinostat 1 Temozolomide 1 Pharmacogenomic Testing 1 Magnetic Resonance Spectroscopy 1 Lithium Carbonate 1 Irinotecan 1 Gefitinib 1 Ferrosoferric Oxide 1 Dexamethasone 1 Capecitabine 1 Bortezomib 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡